Henry Schein (HSIC): analysis and statistics
Return, volatility, Sharpe ratio and risk for Henry Schein, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $85.16 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +2.64% |
| Total return over period | +8.08% |
| Annualized volatility | 26.23% |
| Sharpe ratio | -0.04 |
| Sortino ratio | -0.06 |
| Max drawdown | -24.27% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.45% |
| Correlation with the S&P 500 | 0.30 |
| Period range | $61.89 – $88.26 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Henry Schein (HSIC) has posted an annualized return of +2.64% with annual volatility of 26.23%, a negative Sharpe ratio: over this period it did not beat the risk-free Treasury rate. Its worst stretch (max drawdown from a peak) was -24.27%. Its correlation with the S&P 500 is 0.30, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how HSIC would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with HSIC →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio